Hypertension (High Blood Pressure) News and Research

RSS

Hypertension (or high blood pressure) is a condition where the pressure of the blood flowing through the arteries of the body is higher than it should be. Much like the pressure of the air in a tire, if the pressure of the blood is too high it can damage the arteries and organs of the body. Just like the tire, if the pressure suddenly becomes very high, catastrophic events can happen. Similarly, if the pressure remains somewhat elevated for a long enough period of time, premature wear and failure can occur.

Hypertension has its worst effects on the heart, kidneys, eyes, and brain. High blood pressure is a risk factor for heart attack, stroke, kidney failure, hemorrhages of the retina of the eye, and generalized atherosclerosis (hardening of the arteries all over the body).

Fibromyalgia: an interview with Dr Frederick Wolfe, University of Kansas School of Medicine

Fibromyalgia is a common disorder that is diagnosed in people who have pain in many areas of their body together with important symptoms such as...

22 Mar 2013

Obesity may not diminish outcomes or increase risk of complications in total knee replacement patients

Obesity alone may not diminish outcomes or increase the risk of complications in total knee replacement (TKR) patients, according to two research studies presented today at the 2013 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS). However, TKR replacement patients may face significantly longer hospital stays and related costs.

21 Mar 2013

Cedars-Sinai surgeons perform more adult heart transplants in 2012, statistics show

For the third year in a row, the Cedars-Sinai Heart Institute and Comprehensive Transplant Center performed more adult heart transplants than any other U.S. medical center, according to statistics compiled by the United Network for Organ Sharing, the nonprofit organization that manages the nation's transplant system.

21 Mar 2013

Tivozanib: an interview with Stephen L. Eck, M.D., Ph.D., Vice President, Global Oncology, Astellas Pharma US, Inc. Global Development

Tivozanib is an oral, once-daily, investigational tyrosine kinase inhibitor, or TKI, that is being investigated for use in patients with advanced renal cell carcinoma (RCC), or kidney cancer.

19 Mar 2013

CIHR, CMAJ honour five Canadians for health research excellence

The Canadian Institutes of Health Research and the Canadian Medical Association Journal today honoured five outstanding Canadian individuals and teams. They are the latest recipients of the CIHR-CMAJ Top Canadian Achievements in Health Research Awards, which celebrate Canadian health research excellence.

19 Mar 2013

Controlling hypertension earlier in life may limit brain changes associated with Alzheimer's disease

A study in the JAMA Neurology (formerly the Archives of Neurology) suggests that controlling or preventing risk factors such as hypertension earlier in life may limit or delay the brain changes associated with Alzheimer's disease and other age-related neurological deterioration.

19 Mar 2013

American Heart Association, American Stoke Association to collaborate on national campaign

The American Medical Group Association announced today that the American Heart Association and American Stoke Association will collaborate on Measure Up/Pressure Down, a national campaign to improve high blood pressure prevention, detection and control, spearheaded by the American Medical Group Foundation, AMGA's nonprofit education and research arm.

14 Mar 2013

Researchers show vitamin D supplementation may help African-Americans lower blood pressure

High blood pressure, a risk factor for heart attacks, heart failure and stroke, is 40 percent more common in African-Americans than in other American ethnic groups.

14 Mar 2013

New procedure to treat pseudotumor cerebri

A team of interventional neuroradiologists and neurosurgeons at Johns Hopkins reports wide success with a new procedure to treat pseudotumor cerebri, a rare but potentially blinding condition marked by excessive pressure inside the skull, caused by a dangerous narrowing of a vein located at the base of the brain.

13 Mar 2013

Eplerenone may also reduce risk of heart failure, shows REMINDER trial

The prescription drug eplerenone appears to reduce the risk of cardiovascular mortality and heart failure after a heart attack by more than one-third, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session.

13 Mar 2013

Trial evaluates ranolazine in patients with diabetes, coronary artery disease and angina

A commonly used anti-anginal drug reduces chest pain in patients with type 2 diabetes and appears to have a more pronounced effect in those with poorer glucose control, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session.

13 Mar 2013

RELAX study finds no beneficial effects of erectile dysfunction drug for diastolic heart failure

Despite high expectations for a commonly used erectile dysfunction drug to treat patients with diastolic heart failure, no beneficial effects were found in a study presented today at the American College of Cardiology's 62nd Annual Scientific Session.

13 Mar 2013

$Sildenafil does not improve exercise capacity in HF patients with preserved ejection fraction$

Sildenafil does not improve exercise capacity in HF patients with preserved ejection fraction

Among patients with heart failure with preserved ejection fraction (a measure of heart function), administration of sildenafil for 24 weeks, compared with placebo, did not result in significant improvement in exercise capacity or clinical status, according to a study published online by JAMA.

12 Mar 2013

Study links prenatal DDT exposure to hypertension in adults

Infant girls exposed to high levels of the pesticide DDT while still inside the womb are three times more likely to develop hypertension when they become adults, according to a new study led by the University of California, Davis.

12 Mar 2013

Study identifies why prazosin may cause lightheadedness and fainting

A new study led by a Canadian research team has identified the reason why prazosin, a drug commonly used to reduce high blood pressure, may cause lightheadedness and possible fainting upon standing in patients with normal blood pressure who take the drug for other reasons, such as the treatment of PTSD and anxiety.

12 Mar 2013

New study shows emotions affect health and wellness in low-income countries

Positive emotions are known to play a role in physical well-being, and stress is strongly linked to poor health, but is this strictly a "First World" phenomenon?

11 Mar 2013

Weight loss may help prevent and alleviate symptoms of osteoarthritis

Weight loss may prevent and significantly alleviate the symptoms of osteoarthritis, a progressive disease of the joints known as "wear and tear" arthritis, according to a literature review appearing in the March 2013 issue of the Journal of the American Academy of Orthopaedic Surgeons (JAAOS).

11 Mar 2013

Cardiovascular disease risk in women higher than you think

In conjunction with International Women's Day, the European Cardiology Society reminds women that they may be at a greater risk for cardiovascular disease (CVD) than they think.

8 Mar 2013

Pharmacist-led intervention combats hypertension

A home-based intervention led by clinical pharmacists and involving an internet monitoring tool results in marked reductions in blood pressure, say researchers.

8 Mar 2013

Telemedicine use appears to help urban communities achieve blood pressure goals

Using a telemedicine system to engage people in underserved, urban communities to measure and report their blood pressure remotely-outside of the doctor's office-appears to help them achieve blood pressure goals and improve adherence to lifestyle changes and medication recommendations, according to research being presented at the American College of Cardiology's 62nd Annual Scientific Session.

8 Mar 2013

Hypertension (High Blood Pressure) News and Research

Further Reading

Fibromyalgia: an interview with Dr Frederick Wolfe, University of Kansas School of Medicine

Obesity may not diminish outcomes or increase risk of complications in total knee replacement patients

Cedars-Sinai surgeons perform more adult heart transplants in 2012, statistics show

Tivozanib: an interview with Stephen L. Eck, M.D., Ph.D., Vice President, Global Oncology, Astellas Pharma US, Inc. Global Development

CIHR, CMAJ honour five Canadians for health research excellence

Controlling hypertension earlier in life may limit brain changes associated with Alzheimer's disease

American Heart Association, American Stoke Association to collaborate on national campaign

Researchers show vitamin D supplementation may help African-Americans lower blood pressure

New procedure to treat pseudotumor cerebri

Eplerenone may also reduce risk of heart failure, shows REMINDER trial

Trial evaluates ranolazine in patients with diabetes, coronary artery disease and angina

RELAX study finds no beneficial effects of erectile dysfunction drug for diastolic heart failure

Sildenafil does not improve exercise capacity in HF patients with preserved ejection fraction

Study links prenatal DDT exposure to hypertension in adults

Study identifies why prazosin may cause lightheadedness and fainting

New study shows emotions affect health and wellness in low-income countries

Weight loss may help prevent and alleviate symptoms of osteoarthritis

Cardiovascular disease risk in women higher than you think

Pharmacist-led intervention combats hypertension

Telemedicine use appears to help urban communities achieve blood pressure goals

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News